• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Use of etomidate and ketamine is associated with similar rates of peri-intubation hypotension and mortality

byAlex XiangandSimon Pan
January 13, 2026
in Emergency, Imaging and Intervention
Reading Time: 2 mins read
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Share on FacebookShare on Twitter

1. There was no significant difference in peri-intubation hypotension (PIH) and 28-day mortality between etomidate and ketamine as a single induction agent in elderly patients.

Evidence Rating Level: 2 (Good)

Peri-intubation hypotension (PIH) is a common complication of tracheal intubation with greater risk in elderly patients given the reductive effects of age-related physiological changes and comorbidities on their cardiovascular reserve. Etomidate and ketamine are preferred agents due to their relatively minimal hemodynamic disturbance although data on their use in elderly agents is limited. This study therefore sought to compare the effects of etomidate and ketamine on PIH and 28-day mortality in elderly patients. This prospective, observational cohort study included418 emergency department patients aged 65 years and older requiring tracheal intubation who received either etomidate or ketamine as a single induction agent. PIH was defined as a decrease in systolic blood pressure (SBP) by more than 20% from baseline without treatment, SBP less than 100 mmHg without treatment, or the initiation of vasopressors. The study found no difference in PIH incidence within 30 minutes of medication administration across the two groups (risk difference 9.1 %, 95 % confidence interval [CI] −4.1 to 22.1, p = 0.179) or in 28-day mortality (hazard ratio [HR] 0.66, 95 % CI 0.41–1.07, p = 0.095). However, ketamine was associated with a lower risk of 28-day mortality (adjusted HR 0.59, 95 % CI 0.36–0.97, p = 0.034) in patients who developed PIH and required vasopressors. Furthermore, in patients with a shock index ≥ 0.9, dosage was positively correlated with the probability of PIH in both groups. This study contributes to the existing literature of induction agent selection in tracheal intubation and may support the use of etomidate in certain sub-populations.

Click here to read this study in The American Journal of Emergency Medicine

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

2 Minute Medicine Rewind August 10, 2026

Two scores for risk stratification of adults presenting with syncope may be effective at identifying those with low risk

Tags: 30-day mortalityelderlyemergencyetomidateintubationketamine
Previous Post

Punjab launches AI screening program this week

Next Post

Lilly unveils TuneLab AI platform for biotechs

RelatedReports

Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Emergency

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

August 11, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Computed tomography improves diagnostic certainty in the emergency department
Cardiology

Two scores for risk stratification of adults presenting with syncope may be effective at identifying those with low risk

May 29, 2026
Live attenuated vaccine less effective in recent influenza season
Emergency

Adjuvanted influenza vaccines and high-dose influenza vaccines may have similar effectiveness in adult patients

May 15, 2026
Next Post
Record-based algorithm may improve lung cancer screening follow-up

Lilly unveils TuneLab AI platform for biotechs

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Left atrial appendage closure is safe and effective in atrial fibrillation

A collection of symbolic items such as a microscope

CASPer Exam: Transforming Medical School Admissions

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.